Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol

Keyphrases

• Leukemia Patients 100%
• Acute Lymphoblastic Leukemia 100%
• Adult Patients 100%
• Leukemia-lymphoma 100%
• Lymphoblastic Lymphoma 100%
• Leukemia-free Survival 100%
• B-cell Acute Lymphoblastic Leukemia (B-ALL) 66%
• T-cell Acute Lymphoblastic Leukemia (T-ALL) 66%
• Adult Acute Lymphoblastic Leukemia 66%
• Israel 33%
• Older Adults 33%
• Chemotherapy 33%
• Survival Rate 33%
• Confidence Interval 33%
• Hazard Ratio 33%
• Older Patients 33%
• Minimal Residual Disease 33%
• Philadelphia Chromosome 33%
• Working Diagnosis 33%
• Long-term Survival 33%
• Overall Survival 33%
• Recent Experience 33%
• 5-year Survival 33%
• Normal Karyotype 33%
• Overall Survival Rate 33%
• Relapse Risk 33%
• Adverse Prognosis 33%
• Relapse Rate 33%
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia 33%
• Treatment Paradigms 33%
• Philadelphia Chromosome-negative 33%

Medicine and Dentistry

• Acute Lymphoblastic Leukemia 100%
• Lymphoblastic Lymphoma 100%
• Leukemia 33%
• Philadelphia 1 Chromosome 33%
• Survival Rate 22%
• Overall Survival 22%
• Hazard Ratio 11%
• Minimal Residual Disease 11%
• Karyotype 11%
• Recurrence Risk 11%

Biochemistry, Genetics and Molecular Biology

• Philadelphia Chromosome 100%
• Survival Rate 66%
• Overall Survival 66%
• Karyotype 33%
• Cytogenetics 33%